IP Library Granted Patent US 10,318,712
Granted Patent B2
US 10,318,712 · App. 15/077,493 · Granted Jun 11, 2019

Automated device for biologic drug distribution

Inventor: Michael Har-Noy (Jerusalem, IL)
Assignee: IMMUNOVATIVE THERAPIES, LTD.
G06F19/3462G05B15/02G06F19/00G06Q50/22G07F9/105G07F17/0092
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,318,712
App. No.
15/077,493
Granted
Jun 11, 2019
Kind
B2
Abstract

An apparatus stores and dispenses biologic drug compositions. The apparatus is an automated device that stores a biologic drug under the desired conditions. When authorized, the automated device processes the stored biologic drug by performing the desired processing steps to prepare the biologic drug for administration to a patient. The automated device includes a computing system to transmit patient information to a remote location and receive authorization from a remote location.

Claims (8)

1. An automated device comprising:

a storage chamber in a cooling unit for storing one or more doses of a biologic drug;

a processing compartment within the automated device comprising one or more chambers for processing the one or more doses of the biologic drug, wherein the processing compartment comprises apparatus and materials in the one or more chambers for formulation of the biologic drug prior to administration to a patient and wherein the one or more chambers comprises a mixing chamber for mixing the biologic drug with activating agents;

a system for receiving authorization to move the one or more doses of the biologic drug from the storage chamber to the one or more chambers of the processing compartment; and

a dispensing chamber for receiving the biologic drug from the processing compartment after formulation.

2. The device of claim 1 wherein the cooling unit comprises a freezer for maintaining the biologic drug.

3. The device of claim 2 wherein the freezer maintains the biologic drug at about −70° C.

4. The device of claim 1 wherein the biologic drug comprises T-cells and the activating agents comprise agents that cross-link the CD3 and CD28 cell surface proteins of the T-cells.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE ADDRESS OS THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 050489 FRAME: 0245. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 28, 2020
From: HAR-NOY, MICHAEL
To: MIRROR BIOLOGICS, INC.
Reel/Frame 052915/0513 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR'S NAME FROM IMMUNOVATIVE THERAPIES, LTD. TO MICHAEL HAR-NOY ON THE ORIGINAL COVER SHEET PREVIOUSLY RECORDED ON REEL 050489 FRAME 0245. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 2, 2019
From: HAR-NOY, MICHAEL
To: MIRROR BIOLOGICS, INC.
Reel/Frame 050610/0633 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2019
From: IMMUNOVATIVE THERAPIES, LTD.
To: MIRROR BIOLOGICS, INC.
Reel/Frame 050489/0245 →
RESCISSION Recorded Sep 12, 2019
From: HAR-NOY, MICHAEL
To: HAR-NOY, MICHAEL
Reel/Frame 050467/0081 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2016
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES, LTD.
Reel/Frame 038082/0666 →
Continuity (7)
Continuation 13659290 · Oct 24, 2012
Continuation PCTUS2012055142 · Sep 13, 2012
Provisional Application 61667633 · Jul 3, 2012
Provisional Application 61620651 · Apr 5, 2012
Provisional Application 61561101 · Nov 17, 2011
Provisional Application 61534642 · Sep 14, 2011
Related Publication 20160203295A1 · Jul 14, 2016